Last reviewed · How we verify
NCT02816957: Nigella
Study of The Therapeutic Benefits of Nigella Sativa in Children With Beta Thalassemia Major
EARLY_PHASE1 trial testing nigella sativ in Nigella Sativa With Beta Thalassemia Major in 80 participants. Status unknown.
1 June 2017
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 June 2016 |
| Primary completion | 1 June 2017 |
| Estimated completion | 1 June 2017 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- nigella sativ — full drug profile →
Conditions studied
- Nigella Sativa With Beta Thalassemia Major — all drugs for Nigella Sativa With Beta Thalassemia Major →
Sponsor
Tanta University
Who can join
Adults 3 to 18, any sex, with Nigella Sativa With Beta Thalassemia Major. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
malondialdehyde
Time frame: 3 months
nmol serum level of malondialdehyde (nmol per liter) -
cluster of differentation4 and 8(CD4 and CD8)
Time frame: 3 months
CD4 and CD8 cell per cmm -
total antioxidant
Time frame: 3 months
total antioxidant(mmol per liter)
Sponsor's own description
Evaluate the therapeutic effects health benefits, and immunological effect of Nigella sativa in children with beta thalassemia major.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Immunological, hematological and biochemical benefits of adjuvant nigella sativa to pharmacotherapy in immune thrombocytopenic purpura patients.
Abdelshafy M, El Shanshory M, Shahat K, Al Jaouni SK, et al · · 2026 · PMID 41877935 · DOI 10.62347/dbnq6080
Verify or expand the search:
- PubMed search for NCT02816957
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02816957 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 24 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02816957.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing